Sona Nanotech Inc C.SONA

Alternate Symbol(s): SNANF

Technology Scientific & Technical Instruments

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.

CSE:SONA - Post by User

Sona Nanotech Inc > Evaluating HC results

<< Previous

Bullboard Posts

Next >>

Post by doctorspinon Nov 25, 2020 1:26pm

1153 Views

Post# 31970839

Evaluating HC results

The results of HC evaluations are probably completed and to prevent any premature leaks they halted the stock to evaluate the results and then make a statement regarding those results. My guess is no statement until the end of the trading day IMHO

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading